255 related articles for article (PubMed ID: 30423399)
1. Phosphorylation of serine 305 in tau inhibits aggregation.
Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI
Neurosci Lett; 2019 Jan; 692():187-192. PubMed ID: 30423399
[TBL] [Abstract][Full Text] [Related]
2. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
[TBL] [Abstract][Full Text] [Related]
4. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
5. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
[TBL] [Abstract][Full Text] [Related]
6. Tau protein liquid-liquid phase separation can initiate tau aggregation.
Wegmann S; Eftekharzadeh B; Tepper K; Zoltowska KM; Bennett RE; Dujardin S; Laskowski PR; MacKenzie D; Kamath T; Commins C; Vanderburg C; Roe AD; Fan Z; Molliex AM; Hernandez-Vega A; Muller D; Hyman AA; Mandelkow E; Taylor JP; Hyman BT
EMBO J; 2018 Apr; 37(7):. PubMed ID: 29472250
[TBL] [Abstract][Full Text] [Related]
7. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.
Polanco JC; Scicluna BJ; Hill AF; Götz J
J Biol Chem; 2016 Jun; 291(24):12445-12466. PubMed ID: 27030011
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
[TBL] [Abstract][Full Text] [Related]
10. Using Human iPSC-Derived Neurons to Model TAU Aggregation.
Verheyen A; Diels A; Dijkmans J; Oyelami T; Meneghello G; Mertens L; Versweyveld S; Borgers M; Buist A; Peeters P; Cik M
PLoS One; 2015; 10(12):e0146127. PubMed ID: 26720731
[TBL] [Abstract][Full Text] [Related]
11. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
[TBL] [Abstract][Full Text] [Related]
12. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
13. Cellular factors modulating the mechanism of tau protein aggregation.
Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
[TBL] [Abstract][Full Text] [Related]
14. Designing antibodies against LRRK2-targeted tau epitopes.
Hamm M; Ladd TB; Levites Y; Golde TE; Giasson BI; Lewis J
PLoS One; 2018; 13(9):e0204367. PubMed ID: 30261006
[TBL] [Abstract][Full Text] [Related]
15. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
16. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.
Farmer KM; Ghag G; Puangmalai N; Montalbano M; Bhatt N; Kayed R
Acta Neuropathol Commun; 2020 Aug; 8(1):132. PubMed ID: 32778161
[TBL] [Abstract][Full Text] [Related]
17. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
[TBL] [Abstract][Full Text] [Related]
19. Truncation of Tau selectively facilitates its pathological activities.
Gu J; Xu W; Jin N; Li L; Zhou Y; Chu D; Gong CX; Iqbal K; Liu F
J Biol Chem; 2020 Oct; 295(40):13812-13828. PubMed ID: 32737201
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
